Device recalls soar to 8-quarter high in Q2; CRM market will continue to lag, analysts say;

@FierceMedDev: More trouble for St. Jude as study questions safety of Durata leads. Report | Follow @FierceMedDev

 @MarkHFierce: GE is among three investors who committed $20 million to Ornim, a maker of a non invasive blood flow/oxygen monitor. Release | Follow @MarkHFierce

 @DamianFierce: Maine's medical device middlemen fret over how impending 2.3% tax will cut into profits. More | Follow @DamianFierce

> Device recalls have reached an 8-quarter high, with 123 million units called back in Q2, according to the ExpertRECALL Index. Item

> Thanks to market saturation, the world market for cardiac rhythm management devices will continue to grow at a sluggish pace, according to Millennium Research Group, reaching $9.6 billion in 2016. More

> Medical Device + Diagnostic Industry has published an in-depth rundown of just how the impending 2.3% medical device tax will work. Article

> Medtronic ($MDT) got CE marks for its Viva and Brava cardiac rhythm management devices, and the company plans to file a pre-market application with the FDA. News

> Sotera Wireless got 510(k) clearance for its ViSi Mobile System, a wireless patient monitor. The company has commenced sales to hospitals nationwide. Release

> LabCorp is raising $1 billion in senior notes, planning to spend the money on repaying credit and general corporate expenses. More

> Covalon has snagged FDA clearance for its SurgiClear antimicrobial silicone adhesive film dressing, designed to cover and protect wound sites and wound closure devices. Item

Biotech News

 @FierceBiotech: MediciNova snags $20M deal to finance R&D work. Item | Follow @FierceBiotech

 @JohnCFierce: Kineta uses unorthodox strategy to push autoimmune drug into clinic--my take on an unusual approach to drug development. Editor's Corner | Follow @JohnCFierce

 @RyanMFierce: Closer to mainstream media, Fast Company mag caught up with Sanofi's social strategy for diabetes. More | Follow @RyanMFierce

> Controversial stem cell treatment put to test in groundbreaking autism study. Article

> Buzz: Genomics startup Halcyon Molecular tanks. More

> FDA pushes back PDUFA date on crucial Pfizer app for tofacitinib. Story

> Allergan adds $1.5B R&D pact as it builds ophthalmology pipeline. News

Pharma News

 @FiercePharma: TNF inhibitors-Enbrel, Remicade, Humira, etc.--may actually lower heart attack risks in psoriasis patients. More | Follow @FiercePharma

> GSK to buy in APIs rather than keep Indian plant running. Item

> U.K. to revamp NICE appeals after industry complaints. News

> Novo CFO: Why we're not fussed about new threats to Victoza. Story

> Sanofi pulls Campath to clear way for higher-priced Lemtrada. Article

Pharma Manufacturing News

> Roche CEO says Genentech has resolved Perjeta production problems. Story

> Cambrex puts $19 million in Iowa API plant to fulfill new contract. News

> GSK closes 50-year-old India plant, 'retires' 330. Report

> API growth to spurt in Central, South America. More

Biotech Research News

> Old antifungal drug also fights tumors, researchers discover. Article

> Scientists discover wound-healing secret. Story

> A cool $1M to fund preclinical work on nanotech/siRNA cancer drug. More

> Dana-Farber, Broad Institute spot CYCLOPS gene class in cancer fight. News